CorMedix Inc. (CRMD) Stock Price

CRMDStock
$8.5639.52%52W
Market Cap$667.20M
P/E3.92x
PEG Ratio
Div yield
Beta1.41

CRMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)4.24%
Price vs S&P 500 (4W)9.60%
VGM Score74.11
P/E Ratio (Annual)3.92x

CRMD Earnings Surprise History

Q2 250.28est. 0.19
Q3 251.41est. 0.63
Q4 250.16est. 0.81
Q1 260.35est. 0.33
Q2 260.29est. 0.24

CRMD Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.15
4.17
4.18
4.18

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
CRMDCorMedix Inc.
AAC$8.56
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About CorMedix Inc.

Cormedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases. The company's primary product, DefenCath, is being marketed in the United States and other key markets.